Applied Therapeutics IncNASDAQ:APLT
- LAST PRICE4.7600
- TODAY'S CHANGE (%)0.2300 (5.0773%)
- Bid / Lots4.6300/ 1
- Ask / Lots5.0000/ 2
- Open / Previous Close4.6300 / 4.5300
- Day Range
- 52 Week Range
- Volume622,610
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APLT |
|---|---|---|
| 09:32 ET | 2667 | 4.67 |
| 09:34 ET | 1212 | 4.76 |
| 09:36 ET | 2519 | 4.72 |
| 09:38 ET | 1501 | 4.695 |
| 09:39 ET | 2330 | 4.7385 |
| 09:41 ET | 3304 | 4.78 |
| 09:43 ET | 3265 | 4.78 |
| 09:45 ET | 795 | 4.75 |
| 09:48 ET | 7771 | 4.67 |
| 09:50 ET | 900 | 4.66 |
| 09:52 ET | 2450 | 4.71 |
| 09:54 ET | 3130 | 4.73 |
| 09:56 ET | 949 | 4.74 |
| 09:57 ET | 4007 | 4.72 |
| 09:59 ET | 1025 | 4.73 |
| 10:01 ET | 2334 | 4.72 |
| 10:03 ET | 816 | 4.71 |
| 10:06 ET | 2007 | 4.73 |
| 10:08 ET | 3651 | 4.7 |
| 10:10 ET | 5806 | 4.7 |
| 10:12 ET | 2048 | 4.69 |
| 10:14 ET | 1400 | 4.66 |
| 10:15 ET | 1008 | 4.67 |
| 10:17 ET | 3311 | 4.69 |
| 10:19 ET | 2837 | 4.7 |
| 10:21 ET | 300 | 4.71 |
| 10:26 ET | 1461 | 4.7 |
| 10:28 ET | 669 | 4.69 |
| 10:30 ET | 1350 | 4.71 |
| 10:32 ET | 600 | 4.7 |
| 10:33 ET | 836 | 4.69 |
| 10:35 ET | 2215 | 4.7 |
| 10:37 ET | 1896 | 4.73 |
| 10:39 ET | 1990 | 4.725 |
| 10:44 ET | 1618 | 4.7 |
| 10:46 ET | 400 | 4.69 |
| 10:48 ET | 100 | 4.69 |
| 10:50 ET | 200 | 4.7 |
| 10:51 ET | 300 | 4.7 |
| 10:53 ET | 300 | 4.69 |
| 10:55 ET | 1299 | 4.725 |
| 10:57 ET | 300 | 4.71 |
| 11:00 ET | 1000 | 4.7 |
| 11:02 ET | 300 | 4.7 |
| 11:04 ET | 100 | 4.69 |
| 11:06 ET | 2557 | 4.72 |
| 11:08 ET | 200 | 4.7201 |
| 11:09 ET | 5825 | 4.74 |
| 11:11 ET | 200 | 4.745 |
| 11:13 ET | 1333 | 4.735 |
| 11:15 ET | 316 | 4.745 |
| 11:18 ET | 100 | 4.74 |
| 11:20 ET | 100 | 4.745 |
| 11:22 ET | 3772 | 4.73 |
| 11:24 ET | 700 | 4.7312 |
| 11:26 ET | 1200 | 4.735 |
| 11:27 ET | 200 | 4.73 |
| 11:29 ET | 200 | 4.73 |
| 11:31 ET | 922 | 4.7316 |
| 11:33 ET | 5048 | 4.73 |
| 11:36 ET | 1448 | 4.745 |
| 11:38 ET | 1200 | 4.73 |
| 11:40 ET | 600 | 4.735 |
| 11:42 ET | 400 | 4.73 |
| 11:44 ET | 2132 | 4.745 |
| 11:45 ET | 100 | 4.745 |
| 11:47 ET | 100 | 4.74 |
| 11:49 ET | 100 | 4.745 |
| 11:51 ET | 842 | 4.74 |
| 11:54 ET | 3115 | 4.75 |
| 11:56 ET | 2515 | 4.75 |
| 11:58 ET | 100 | 4.75 |
| 12:02 ET | 342 | 4.757 |
| 12:03 ET | 300 | 4.755 |
| 12:05 ET | 3773 | 4.76 |
| 12:07 ET | 300 | 4.74 |
| 12:09 ET | 900 | 4.755 |
| 12:12 ET | 800 | 4.75 |
| 12:14 ET | 1349 | 4.76 |
| 12:16 ET | 1050 | 4.75 |
| 12:18 ET | 1131 | 4.755 |
| 12:20 ET | 3083 | 4.76 |
| 12:21 ET | 100 | 4.75 |
| 12:23 ET | 100 | 4.75 |
| 12:25 ET | 5042 | 4.79 |
| 12:27 ET | 1400 | 4.795 |
| 12:30 ET | 425 | 4.8 |
| 12:32 ET | 3570 | 4.77 |
| 12:34 ET | 1200 | 4.78 |
| 12:36 ET | 1300 | 4.775 |
| 12:38 ET | 600 | 4.775 |
| 12:39 ET | 961 | 4.775 |
| 12:41 ET | 300 | 4.76 |
| 12:43 ET | 600 | 4.765 |
| 12:45 ET | 4129 | 4.79 |
| 12:48 ET | 100 | 4.785 |
| 12:50 ET | 1389 | 4.775 |
| 12:52 ET | 600 | 4.78 |
| 12:54 ET | 200 | 4.77 |
| 12:56 ET | 945 | 4.77 |
| 12:57 ET | 1700 | 4.775 |
| 12:59 ET | 613 | 4.7799 |
| 01:01 ET | 300 | 4.775 |
| 01:03 ET | 1014 | 4.77 |
| 01:06 ET | 1100 | 4.7712 |
| 01:08 ET | 1132 | 4.775 |
| 01:10 ET | 700 | 4.775 |
| 01:12 ET | 600 | 4.77 |
| 01:14 ET | 3947 | 4.765 |
| 01:17 ET | 500 | 4.765 |
| 01:19 ET | 800 | 4.77 |
| 01:21 ET | 5500 | 4.795 |
| 01:24 ET | 200 | 4.795 |
| 01:26 ET | 100 | 4.79 |
| 01:28 ET | 300 | 4.79 |
| 01:30 ET | 100 | 4.785 |
| 01:32 ET | 310 | 4.785 |
| 01:33 ET | 200 | 4.78 |
| 01:35 ET | 100 | 4.78 |
| 01:37 ET | 1505 | 4.79 |
| 01:42 ET | 100 | 4.795 |
| 01:44 ET | 700 | 4.79 |
| 01:46 ET | 200 | 4.785 |
| 01:48 ET | 800 | 4.795 |
| 01:51 ET | 648 | 4.785 |
| 01:53 ET | 100 | 4.79 |
| 01:55 ET | 300 | 4.78 |
| 01:57 ET | 1921 | 4.795 |
| 02:00 ET | 1696 | 4.79 |
| 02:04 ET | 100 | 4.78 |
| 02:08 ET | 1300 | 4.79 |
| 02:11 ET | 7494 | 4.845 |
| 02:13 ET | 4382 | 4.845 |
| 02:15 ET | 400 | 4.845 |
| 02:18 ET | 400 | 4.848 |
| 02:20 ET | 1504 | 4.845 |
| 02:22 ET | 100 | 4.84 |
| 02:24 ET | 800 | 4.84 |
| 02:26 ET | 700 | 4.845 |
| 02:27 ET | 1100 | 4.83 |
| 02:29 ET | 2100 | 4.84 |
| 02:31 ET | 300 | 4.83 |
| 02:33 ET | 600 | 4.835 |
| 02:36 ET | 2500 | 4.835 |
| 02:38 ET | 700 | 4.83 |
| 02:40 ET | 777 | 4.84 |
| 02:42 ET | 600 | 4.835 |
| 02:44 ET | 1772 | 4.8275 |
| 02:45 ET | 3746 | 4.82 |
| 02:47 ET | 1200 | 4.8 |
| 02:49 ET | 8204 | 4.81 |
| 02:51 ET | 300 | 4.81 |
| 02:54 ET | 200 | 4.82 |
| 02:56 ET | 5813 | 4.83 |
| 02:58 ET | 11958 | 4.815 |
| 03:00 ET | 500 | 4.81 |
| 03:02 ET | 3509 | 4.805 |
| 03:03 ET | 1336 | 4.8 |
| 03:05 ET | 1200 | 4.795 |
| 03:07 ET | 1300 | 4.78 |
| 03:09 ET | 920 | 4.78 |
| 03:12 ET | 1257 | 4.77 |
| 03:14 ET | 6235 | 4.78 |
| 03:16 ET | 200 | 4.78 |
| 03:18 ET | 300 | 4.78 |
| 03:20 ET | 800 | 4.785 |
| 03:21 ET | 4200 | 4.77 |
| 03:23 ET | 3807 | 4.76 |
| 03:25 ET | 2700 | 4.75 |
| 03:27 ET | 4074 | 4.75 |
| 03:30 ET | 2081 | 4.75 |
| 03:32 ET | 6630 | 4.75 |
| 03:34 ET | 848 | 4.75 |
| 03:36 ET | 1736 | 4.755 |
| 03:38 ET | 200 | 4.75 |
| 03:39 ET | 2550 | 4.7518 |
| 03:41 ET | 1422 | 4.75 |
| 03:43 ET | 4673 | 4.75 |
| 03:45 ET | 635 | 4.75 |
| 03:48 ET | 8369 | 4.775 |
| 03:50 ET | 5919 | 4.77 |
| 03:52 ET | 600 | 4.77 |
| 03:54 ET | 3137 | 4.77 |
| 03:56 ET | 35148 | 4.785 |
| 03:57 ET | 9612 | 4.765 |
| 03:59 ET | 38164 | 4.76 |
Apr 15, 2024
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer, from 7:00AM ET on Monday Apr 15, 2024 by Dow Jones
7:00AM ET on Monday Apr 15, 2024 by Dow JonesPress Release: Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer, from 7:00AM ET on Monday Apr 15, 2024 by Dow Jones
7:00AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 11, 2024
DJ Applied Therapeutics Price Target Maintained With a $12.00/Share by RBC Capital, from 10:42AM ET on Thursday Apr 11, 2024 by Dow Jones
10:42AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 4, 2024
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024, from 7:00AM ET on Thursday Apr 04, 2024 by Dow Jones
7:00AM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Applied Therapeutics Inc | 543.8M | -3.3x | --- |
Verve Therapeutics Inc | 537.9M | -2.0x | --- |
Northwest Biotherapeutics Inc | 547.4M | -8.0x | --- |
Absci Corp | 574.5M | -4.2x | --- |
Korro Bio Inc | 540.0M | -0.9x | --- |
Adlai Nortye Ltd | 508.5M | -1.9x | --- |
Company Information
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Contact Information
- Headquarters
- 545 FIFTH AVENUE, SUITE 1400NEW YORK, NY, United States 10017
- Phone
- 212-220-9226
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Founder
- Shoshana Shendelman
- Chief Financial Officer and Principal Financial Officer, Director
- Leslie Funtleyder
- Chief Operating Officer and Chief Business Officer
- Constantine Chinoporos
- Chief Accounting Officer
- Catherine Thorpe
- Chief Commercial Officer
- Dale Hooks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $543.8M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.91 |
EPS | $-1.42 |
Book Value | $-0.20 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 54.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -645.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
